Share on LinkedInShare on LinkedIn

ARTICLE · 20 NOVEMBER 2025

CANDID vs. CANDEX-B Judgment: A Conundrum!

S.S. Rana & Co.
S.S. Rana & Co.
Contributor
S.S. Rana & Co.

S.S. Rana & Co.

Established in 1989, S.S. Rana & Co. is a premier intellectual property and corporate law firm...

View firm profile
Explore more from S.S. Rana & Co.

In the present case, Karlin Pharmaceuticals & Exports (first respondent) had filed Application No.749366 dated March 21, 1997 (on a proposed to be used basis), seeking registration of the trademark ‘CANDEX-B' for pharmaceutical products in class 5.

IndiaIntellectual Property

Brief Facts

In the present case, Karlin Pharmaceuticals & Exports (first respondent) had filed Application No.749366 dated March 21, 1997 (on a proposed to be used basis), seeking registration of the trademark 'CANDEX-B' for pharmaceutical products in class 5. The mark was published in the Trade Marks Journal on August 16, 2007. Subsequently, the appellant, Glenmark Pharmaceuticals Ltd. filed Opposition No. 716540 against the said application on January 22, 2008, inter alia on the basis that the said mark is similar to their prior mark 'CANDID'. Subsequently, the Counter Statement was filed by the respondent on April 11, 2008. Subsequently, after the prosecution of the application and the hearing in respect of the captioned matter, by the impugned order dated July 26, 2013 passed by the Registrar of Trade Marks (second respondent), the opposition was rejected and the mark was granted registration.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from